These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 2872603

  • 1. Beta adrenergic control of extrarenal potassium disposal. A beta-2 mediated phenomenon.
    Bia MJ, Lu D, Tyler K, De Fronzo RA.
    Nephron; 1986; 43(2):117-22. PubMed ID: 2872603
    [Abstract] [Full Text] [Related]

  • 2. Adrenergic modulation of extrarenal potassium disposal.
    Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, Epstein FH.
    N Engl J Med; 1980 Feb 21; 302(8):431-4. PubMed ID: 6101508
    [Abstract] [Full Text] [Related]

  • 3. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
    Yang WC, Huang TP, Ho LT, Chung HM, Chan YL, Batlle DC.
    Miner Electrolyte Metab; 1986 Feb 21; 12(3):186-93. PubMed ID: 2873504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influences of thyroid status and sympathoadrenal system on extrarenal potassium disposal.
    Kubota K, Ingbar SH.
    Am J Physiol; 1990 Mar 21; 258(3 Pt 1):E428-35. PubMed ID: 1969231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia.
    Martinez Vea A, Montoliu J, Andreu L, Torras A, Gaya J, López-Pedret J, Revert L.
    Proc Eur Dial Transplant Assoc; 1983 Mar 21; 19():756-60. PubMed ID: 6136035
    [Abstract] [Full Text] [Related]

  • 11. Can the biochemical responses to a beta 2-adrenoceptor stimulant be used to assess the selectivity of beta-adrenoceptor blockers?
    Rolf Smith S, Kendall MJ, Worthington DJ, Holder R.
    Br J Clin Pharmacol; 1983 Nov 21; 16(5):557-60. PubMed ID: 6139123
    [Abstract] [Full Text] [Related]

  • 12. Coexistence of beta 2- and beta 3-adrenoceptors in plasma potassium control in conscious rabbits.
    Reverte M, García-Barrado MJ, Hernández-García FJ, Moratinos J.
    J Auton Pharmacol; 1993 Jun 21; 13(3):227-36. PubMed ID: 8099912
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Calcium channel blockers enhance extrarenal potassium disposal in the rat.
    Sugarman A, Kahn T.
    Am J Physiol; 1986 Apr 21; 250(4 Pt 2):F695-701. PubMed ID: 3083698
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone impairs extrarenal potassium tolerance in the rat.
    Sugarman A, Kahn T.
    Am J Physiol; 1988 Mar 21; 254(3 Pt 2):F385-90. PubMed ID: 3348415
    [Abstract] [Full Text] [Related]

  • 19. Epinephrine and potassium homeostasis.
    DeFronzo RA, Bia M, Birkhead G.
    Kidney Int; 1981 Jul 21; 20(1):83-91. PubMed ID: 7300118
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.